Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®
Clinical trial NCT00042094 · COMPLETED
Trial details
- NCT number
- NCT00042094
- Sponsor
- DynPort Vaccine Company LLC, A GDIT Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.